{"id":851810,"date":"2025-05-16T05:50:42","date_gmt":"2025-05-16T09:50:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/"},"modified":"2025-05-16T05:50:42","modified_gmt":"2025-05-16T09:50:42","slug":"june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/","title":{"rendered":"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">May 16, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in <b>Cerevel Therapeutics Holdings, Inc.<\/b> (&#8220;Cerevel Therapeutics Holdings, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ABBV) of a class action securities lawsuit.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg\" title=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" alt=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>CLASS DEFINITION: <\/b>The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by <span>alleged<\/span> securities <span>fraud<\/span>. This lawsuit is on behalf of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from <span class=\"xn-chron\">October 11, 2023<\/span> through <span class=\"xn-chron\">August 1, 2024<\/span>, inclusive. (b) held shares of Cerevel as of the <span class=\"xn-chron\">January 8, 2024<\/span> record date and were entitled to vote on the merger of Cerevel and AbbVie Inc. (c) sold shares of Cerevel stock contemporaneously with Bain Capital&#8217;s purchase of shares on or about October 16, 2023. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/zlk.com\/pslra-1\/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=148643&amp;wire=4\" rel=\"nofollow\">https:\/\/zlk.com\/pslra-1\/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=148643&amp;wire=4<\/a>\n      <\/p>\n<p>\n        <b>ABBV<\/b>\u00a0investors may also contact <span class=\"xn-person\">Joseph E. Levi, Esq.<\/span> via email <a href=\"mailto:at\u00a0jlevi@levikorsinsky.com\u00a0or\" rel=\"nofollow\">at\u00a0jlevi@levikorsinsky.com\u00a0or<\/a> by telephone at (212) 363-7500.<\/p>\n<p>\n        <b>CASE DETAILS: <\/b>According to the complaint, Cerevel&#8217;s <span class=\"xn-chron\">October 16, 2023<\/span> secondary stock offering (the &#8220;October Offering&#8221; or &#8220;Offering&#8221;) documents and other public statements omitted material facts regarding AbbVie&#8217;s interest in acquiring Cerevel at a price well in excess of the <span class=\"xn-money\">$22.81<\/span> per share Offering price, artificially deflating Cerevel&#8217;s stock price until the merger was announced. Moreover, Cerevel&#8217;s controlling shareholder, Bain Capital Investors, LLC (&#8220;Bain&#8221;), acquired Cerevel shares from the October Offering at an artificially depressed price while <span>allegedly<\/span> in possession of material nonpublic information regarding AbbVie&#8217;s interest. On <span class=\"xn-chron\">December 6, 2023<\/span>, Cerevel publicly announced that AbbVie agreed to acquire Cerevel for <span class=\"xn-money\">$45<\/span> per share. The merger allowed Bain to receive a windfall of more than <span class=\"xn-money\">$120 million<\/span> on the shares it acquired at the artificially depressed Offering price. In addition, Cerevel&#8217;s <span class=\"xn-chron\">January 18, 2024<\/span> Proxy statement misled investors regarding the true nature and timing of AbbVie&#8217;s interest in Cerevel.<\/p>\n<p>\n        <b>WHAT&#8217;S NEXT? <\/b>If you suffered a loss in Cerevel Therapeutics Holdings, Inc. during the relevant time frame, you have until <b><span class=\"xn-chron\">June 3, 2025<\/span><\/b>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <b>NO COST TO YOU: <\/b>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <b>There is no cost or obligation to participate.<\/b><\/p>\n<p>\n        <b>WHY LEVI &amp; KORSINSKY: <\/b>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services&#8217; Top 50 Report as one of the top securities litigation firms in <span class=\"xn-location\">the United States<\/span>.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/><span class=\"xn-person\">Joseph E. Levi, Esq.<\/span><br \/><span class=\"xn-person\">Ed Korsinsky, Esq.<\/span><br \/>33 Whitehall Street, 17th Floor<br \/><span class=\"xn-location\">New York, NY<\/span> 10004<br \/><a href=\"mailto:jlevi@levikorsinsky.com\" rel=\"nofollow\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4429284-7&amp;h=1549134502&amp;u=https%3A%2F%2Fwww.zlk.com%2F&amp;a=www.zlk.com\" target=\"_blank\" rel=\"nofollow\">www.zlk.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY89567&amp;sd=2025-05-16\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/june-3-2025-deadline-contact-levi--korsinsky-to-join-class-action-suit-against-abbv-302457215.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/june-3-2025-deadline-contact-levi&#8211;korsinsky-to-join-class-action-suit-against-abbv-302457215.html<\/a><\/p>\n<p>SOURCE  Levi &amp; Korsinsky, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY89567&amp;Transmission_Id=202505160545PR_NEWS_USPR_____NY89567&amp;DateId=20250516\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , May 16, 2025 \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. (&#8220;Cerevel Therapeutics Holdings, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ABBV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive. (b) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-851810","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , May 16, 2025 \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. (&#8220;Cerevel Therapeutics Holdings, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ABBV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive. (b) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc. &hellip; Continue reading &quot;June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-16T09:50:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV\",\"datePublished\":\"2025-05-16T09:50:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/\"},\"wordCount\":540,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/\",\"name\":\"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"datePublished\":\"2025-05-16T09:50:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/","og_locale":"en_US","og_type":"article","og_title":"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV - Market Newsdesk","og_description":"PR Newswire NEW YORK , May 16, 2025 \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. (&#8220;Cerevel Therapeutics Holdings, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ABBV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive. (b) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc. &hellip; Continue reading \"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-16T09:50:42+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV","datePublished":"2025-05-16T09:50:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/"},"wordCount":540,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/","name":"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","datePublished":"2025-05-16T09:50:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/june-3-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-abbv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"June 3, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against ABBV"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/851810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=851810"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/851810\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=851810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=851810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=851810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}